YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2024ATTLAS, IMpower151 and ORIENT-31: Dusting off IMpower150 for Post-Osimertinib in EGFR-Mutated NSCLC? Lung Cancer : targets and therapy
2024Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey Lung Cancer : targets and therapy
2024Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomes CARDIOVASCULAR REVASCULARIZATION MEDICINE
2024Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis JHEP REPORTS
2024Trends and socioeconomic inequality of the burden of congenital abnormalities of the kidney and urinary tract among children and adolescentsNEPHROLOGY DIALYSIS TRANSPLANTATION
2024A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver diseaseHEPATOLOGY INTERNATIONAL
2024Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3 ANNALS OF ONCOLOGY
2024Polycaprolactone (PCL) Film-Covered Bare Metal Stent: A Remedied Fire Extinguisher? KOREAN CIRCULATION JOURNAL
2024A Unified Approach For Comprehensive Analysis of Various Spectral and Tissue Doppler EchocardiographyIEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING, ISBI 2024
2024Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin MicrosphereCARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
2024Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancer CANCER SCIENCE
2024PACIFIC-9: Phase III trial of durvalumab + oleclumab or monalizumab in unresectable stage III non-small-cell lung cancer FUTURE ONCOLOGY
2024Capivasertib and fulvestrant for patients with hormone receptor-positive advanced breast cancer: characterization, time course, and management of frequent adverse events from the phase III CAPItello-291 study ESMO OPEN
2024A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17) ESMO OPEN
2024Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes CARDIOVASCULAR DIABETOLOGY
2024Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 StudyCANCER
2024ASO Visual Abstract: Left Upper Division Segmentectomy Compared with Lobectomy for Lung Expansion and Bronchus TortuosityANNALS OF SURGICAL ONCOLOGY
2024Differentiation Between Invasive Adenocarcinoma and Focal Interstitial Fibrosis among Persistent Pulmonary Part-solid Nodules: With Emphasis on the CT Morphologic AnalysisJOURNAL OF THORACIC IMAGING
2024Nationwide Trends in Helicobacter pylori Eradication Therapies in Korea: Impact of Guideline Updates on Treatment PracticesHELICOBACTER
2024PM2.5 constituents associated with mortality and kidney failure in childhood-onset lupus nephritis: A 19-year cohort studySCIENCE OF THE TOTAL ENVIRONMENT
1 30 3132333435363738394041 771

Recent Submissions

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links